New Insights on Hyperbaric Oxygen Therapy for Cancer
- Authors
-
-
Michael J. González
University of Puerto Rico, Medical Sciences Campus, School of Public Health, USA; EDP University, Naturopathic Sciences Program, USA; Universidad Central del Caribe, School of Chiropractic, USA; Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA and Berdiel Clinic, Ponce Puerto Rico, USA -
Jorge R. Miranda-Massari
University of Puerto Rico, Medical Sciences Campus, School of Pharmacy, USA and EDP University, Naturopathic Sciences Program, USA -
Michael Joseph Gonzalez
Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA -
Jose Olalde
Centro Médico Regenerativo (CMR), Bayamón and Caguas Puerto Rico, USA -
Miguel J. Berdiel
Berdiel Clinic, Ponce Puerto Rico, USA -
Liza Cardona
EDP University, Naturopathic Sciences Program, USA
-
- Keywords:
- Hyperbaric Oxygen, Cancer, oxygen, degenerative diseases, hypoxia, senesence
- Abstract
-
Hypoxia is a critical characteristic of malignant tumors and involves enhanced cell survival, angiogenesis, glycolytic metabolism, and metastasis. Hyperbaric oxygen treatment (HBOT) has been used to improve and cure disorders involving hypoxia and ischemia, HBOT enhances the amount of dissolved oxygen in the plasma and thereby increasing O2 delivery to the tissue. Studies on HBOT and cancer have mostly focused on whether enhanced oxygen may act as a promoter of cancer. As oxygen is believed to be required for all the major processes of wound healing, including angiogenesis, this particular idea would give the impression that HBOT will promote cancer growth and recurrence. Nevertheless, this is not the case since the use of HBOT in patients with malignancies should be considered safe and therapeutic. There is no evidence indicating that HBO neither acts as a stimulator of tumor growth nor as an enhancer of recurrence. On the other hand, there is evidence that implies that HBO has tumor-inhibitory effects, this manuscript pretends to expand our knowledge on the effect and the mechanisms behind tumor oxygenation by HBOT.
- References
-
Chen SY, Tsuneyama K, Yen MH, Lee JT, Chen JL, Huang SM. Hyperbaric oxygen suppressed tumor progression through the improvement of tumor hypoxia and induction of tumor apoptosis in A549-cell-transferred lung cancer. Sci Rep 2021; 11(1):12033. https://doi.org/10.1038/s41598-021-91454-2
Manish KC, Rodriguez JR, Gonzalez FL, Arroyo NA, Garcia KM, Olalde J, Berdiel MJ, Morales-Borges R, Miranda-Massari JR, Gonzalez MJ. Research advances in hyperbaric oxygen therapy use in cancer: A Review. Am Res J Oncology 2021; 3(1): 1-6.
Poff AM, Ari C, Seyfried TN, D'Agostino DP. The ketogenic diet and hyperbaric oxygen therapy prolong survival in mice with systemic metastatic cancer. PLoS One 2013; 8(6): e65522. https://doi.org/10.1371/journal.pone.0065522
Moen I, Stuhr LE. Hyperbaric oxygen therapy and cancer a review. Target Oncol 2012; 7(4): 233-42. https://doi.org/10.1007/s11523-012-0233-x
Daruwalla J, Christophi C. Hyperbaric oxygen therapy for malignancy: a review. World J Surg 2006; 30(12): 2112-31. https://doi.org/10.1007/s00268-006-0190-6
Herrera-Campos AB, Zamudio-Martinez E, Delgado-Bellido D, Fernández-Cortés M, Montuenga LM, Oliver FJ, Garcia-Diaz A. Implications of Hyperoxia over the Tumor Microenvironment: An Overview Highlighting the Importance of the Immune System. Cancers (Basel) 2022; 14(11): 2740. https://doi.org/10.3390/cancers14112740
Narkowicz C K, Vial JH and McCartney PW. Hyperbaric Oxygen Therapy Increases Free Radical Levels in the Blood of Humans, Free Radical Research Communications 1993; 19(2): 71-80. https://doi.org/10.3109/10715769309056501
Weber SU, Koch A, Kankeleit J, Schewe JC, Siekmann U, Stüber F, Hoeft A, Schröder S. Hyperbaric oxygen induces apoptosis via a mitochondrial mechanism. Apoptosis 2009; 14(1): 97-107. https://doi.org/10.1007/s10495-008-0280-z
Gonzalez MJ, Seyfried T, Nicolson GL, Barclay BJ, Matta J, Vasquez A, D’ Agostino D, Olalde J, Duconge J, Hunninghake R, Berdiel MJ, Cintrón A. Mitochondrial Correction: A New Therapeutic Paradigm for Cancer and Degenerative Diseases. J Orthomolec Med 2018; 33(4): 1-20.
Hadanny A, Forer R, Volodarsky D, Daniel-Kotovsky M, Catalogna M, Zemel Y, Bechor Y, Efrati S. Hyperbaric oxygen therapy induces transcriptome changes in elderly: a prospective trial. Aging (Albany NY) 2021; 13(22): 24511-24523. https://doi.org/10.18632/aging.203709
Gupta K, Madan E, Sayyid M, Arias-Pulido H, Moreno E, Kuppusamy P, Gogna R. Oxygen regulates molecular mechanisms of cancer progression and metastasis. Cancer Metastasis Rev 2014; 33(1): 183-215. https://doi.org/10.1007/s10555-013-9464-2
Dave KR, Prado R, Busto R, Raval AP, Bradley WG, Torbati D, Pérez-Pinzón MA. Hyperbaric oxygen therapy protects against mitochondrial dysfunction and delays onset of motor neuron disease in Wobbler mice. Neuroscience 2003; 120(1): 113-120. https://doi.org/10.1016/S0306-4522(03)00244-6
Rossignol DA, Bradstreet JJ, Van Dyke K, Schneider C, Freedenfeld SH, O’Hara N, Cave S, Buckley JA, Mumper EA, Frye RE. Hyperbaric oxygen treatment in autism spectrum disorders. Med Gas Res 2012; 2(16). https://doi.org/10.1186/2045-9912-2-16
Palzur E, Zaaroor M, Vlodavsky E, Milman F, Soustiel JF. Neuroprotective effect of hyperbaric oxygen therapy in brain injury is mediated by preservation of mitochondrial membrane properties. Brain Res 2008; 1221: 126-133. https://doi.org/10.1016/j.brainres.2008.04.078
Poff AM, Ward N, Seyfried TN, Arnold P, D’Agostino DP. Non-toxic metabolic management of metastatic cancer in VM mice: novel combination of ketogenic diet, ketone supplementation and hyperbaric oxygen therapy. PLoS One 2015; 10: e0127407. https://doi.org/10.1371/journal.pone.0127407
Lin PY, Sung PH, Chung SY, Hsu SL, Chung WJ, Sheu JJ, Hsueh SK, Chen KH, Wu RW, Yip HK. Hyperbaric Oxygen Therapy Enhanced Circulating Levels of Endothelial Progenitor Cells and Angiogenesis Biomarkers, Blood Flow, in Ischemic Areas in Patients with Peripheral Arterial Occlusive Disease. J Clin Med 2018; 7(12): 548. https://doi.org/10.3390/jcm7120548
Memar MY, Yekani M, Alizadeh N, Baghi HB. Hyperbaric oxygen therapy: Antimicrobial mechanisms and clinical application for infections. Biomed Pharmacother 2019; 109: 440-447. https://doi.org/10.1016/j.biopha.2018.10.142
Yang C, Liu G, Zeng X, Xiang Y, Chen X, Le W. Therapeutic effects of long-term HBOT on Alzheimer's disease neuropathologies and cognitive impairment in APPswe/PS1dE9 mice. Redox Biol 2024; 70: 103006. https://doi.org/10.1016/j.redox.2023.103006
Hink J, Jansen E. Are superoxide and/or hydrogen peroxide responsible for some of the beneficial effects of hyperbaric oxygen therapy? Medical Hypotheses 2001; 57: 764-769. https://doi.org/10.1054/mehy.2001.1488
- Downloads
- Published
- 2024-06-12
- Issue
- Vol. 13 (2024)
- Section
- Articles
- License
-

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
Similar Articles
- Pedro Salinas Hernández, Rafael Trujillo Vilchez, Antonio Arriví García-Ramos, Rosana Grande Ladron de Guevara, Angeles Rodríguez Jaraiz, Pedro Gallurt Moreira, Jose Maria Vieitez de Prado, Miguel Ruiz López de Tejada, Antonio Irigoyen Medina, Juan Manuel Campos Cervera, Juan Carlos Cámara Vicario, Uriel Bohn Sarmiento, Pedro López Tendero, Juan Domingo Alonso Lajara, Ana León Carbonero, Marisa García de Paredes, Juan de Alvaro Liaño, Asunción Juarez Marroquí, Luis López Gómez , Diego Soto de Prado Otero, Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Sajad Ahmad Salati, Lamees Sulaiman Alsulaim, Sister Mary Joseph Nodule (SMJN) – A Review , Journal of Analytical Oncology: Vol. 12 (2023)
- Paola Fernanda Fedatto, Thais Inácio de Carvalho, Jaqueline Carvalho de Oliveir, David Santos Marco Antônio, Julia Alejandra Pezuk, Daniela Pretti da Cunha Tirapell, Omar Féres, osé Joaquim Ribeiro da Rocha, Carlos Alberto Scrideli, Luiz Gonzaga Tone, María Sol Brassesco, MiR-708-5p as a Predictive Marker of Colorectal Cancer Prognosis , Journal of Analytical Oncology: Vol. 5 No. 1 (2016)
- Vladimir Zaichick, Differences between 66 Chemical Element Contents in Normal and Cancerous Prostate , Journal of Analytical Oncology: Vol. 6 No. 2 (2017)
- Yaqin Yuan, Hao Qiu, Jingdong Gao, Zerong Wang, Chunliang Liu, Zhenhua Liu, Zhi Jiang, Yongjian Li, Shiliang Wu, Triptolide Inhibits MCF-7 and HepG2 Cells Invasion and Migration by Inhibiting the Synthesis of Polylactosamine Chains , Journal of Analytical Oncology: Vol. 5 No. 3 (2016)
- L. Thorslund, M. Falk, Patient Performed Reading of a Phototest - A Reliable Method? , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- T.P. Artsemyeva, D.A. Tzerkovsky, Efficacy of Photodynamic Therapy with Chlorine-Based Photosensitizer in the Treatment of Basal Cell Carcinomas , Journal of Analytical Oncology: Vol. 12 (2023)
- A.S. Kirthi Koushik, R.C. Alva, Brachytherapy in Head and Neck Cancer: A Forgotten Art or a Skill to be Remembered!! , Journal of Analytical Oncology: Vol. 6 No. 1 (2017)
- Darrell B. Tata, Ilko K. Ilev, Non-Invasive Real-Time Monitoring and Label-Free Sensing of Hydrogen Peroxide in Human Brain Cancer Cells Through Raman Spectroscopy , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
- Martin Czejka, Andreas Kiss, Eva Ostermann, Johannes Schueller, Mansoor Ahmed, Najia Mansoor, Tasneem Ahmad, Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
You may also start an advanced similarity search for this article.
